The analysis of clinical samples showed that the FOXP2-improved survival in patients depended on the high expression of FOXA2 in breast cancer (see Figure 6B), implicating involvement of FOXA2 for FOXP2 performing its functions. The gene discussed is FOXA2; the disease is breast carcinoma.